Brain training game aims to boost processing speed in young cancer survivors
NCT ID NCT07558473
First seen Jun 27, 2026 · Last updated Aug 07, 2026 · Updated 1 time
Summary
This study tests whether a simple online computer game can help children with brain tumors think faster. 300 kids will do 15 minutes of cognitive training, 5 times a week for 8 weeks. Researchers will check if the training is easy to do at home and if it actually improves processing speed and daily thinking skills.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- online computerized cognitive training
- What this could lead to
- If it works, this could offer a simple, at-home way to help children with brain tumors think and process information faster.
- What could go wrong
- This is a small, early feasibility study with no comparison group, so it cannot prove the training works. The effect may be small or not last long.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 300 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jul 2026
An estimate. Start dates often move.
- Expected to finish
-
Apr 2033
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
5 to 25 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Diagnosis of a primary brain tumor, 2. Children and young adults 5 to 25 years of age at the time of enrollment, 3. Within five years of initial brain tumor diagnosis, 4. Receiving care through the Johns Hopkins neuro-oncology program. Exclusion Criteria: 1. Significant visual, hearing, motor, or cognitive impairment that precludes participation in computerized cognitive training program; 2. Acute medical status (e.g., significant risk for mortality within 3-months of diagnosis).
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Brain tumor are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Kennedy Krieger Institute
Baltimore, Maryland, 21205, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- One extra radiation dose after standard brain cancer therapy: can it boost the immune system?
- Zapping the brain to restore lost vision
- Brain surgery delirium: can real-time monitoring protect older patients?
- Music as medicine: could ukulele lessons rebuild young brains after cancer?
- Can trained immune cells outsmart brain tumors?
- Childhood brain tumor survivors face hidden hormone risks years later